SCD and osteosarcoma: Immunofluorescence staining showed that higher B1 doses led to decreased levels of SCD and GPX4 in osteosarcoma tissues (Fig. S7A), while reactive oxygen species (ROS) (Fig. S7B) and lipid peroxidation (Fig. S7C) levels increased in a dose-dependent manner.